Bench-to-bedside review: Clinical experience with the endotoxin activity assay

Critical Care

Volumn 16, Issue 6, 2012, Pages

  Romaschin, Alexander D ^a   Klein, David J ^a   Marshall, John C ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; ENDOTOXIN; EPITOPE; FATTY ACID BINDING PROTEIN 2; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; POLYMYXIN B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; LIPOPOLYSACCHARIDE;

ABDOMINAL SURGERY; BIOASSAY; BODY FLUID; CARDIOVASCULAR SURGERY; CLINICAL TRIAL (TOPIC); CONGENITAL HEART DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; ENDOTOXEMIA; ENDOTOXIN ACTIVITY ASSAY; ENDOTOXIN DETECTION; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; GRAM NEGATIVE SEPSIS; GRAM POSITIVE INFECTION; HOSPITAL PATIENT; HUMAN; INJURY; INTENSIVE CARE UNIT; LIMULUS LYSATE TEST; MICROARRAY ANALYSIS; MONOCYTE; MORTALITY; MULTIPLE TRAUMA; MYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; PORTOCAVAL SHUNT; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY BURST; REVIEW; RISK; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BLOOD; DIAGNOSTIC USE; INTENSIVE CARE; PROCEDURES;

BIOLOGICAL ASSAY; ENDOTOXEMIA; ENDOTOXINS; HUMANS; INTENSIVE CARE; LIPOPOLYSACCHARIDES; POLYMYXIN B;

EID: 84870528963     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11495     Document Type: Review

References (26)

1. Opal SM. The host response to endotoxin, antilipopolysaccharide strategies and the management of severe sepsis. Int J Med Microbiol 2007, 297:365-377. 10.1016/j.ijmm.2007.03.006, 17452016.
2. Munford RS. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?. Infect Immun 2008, 76:454-465. 10.1128/IAI.00939-07, 2223455, 18086818.
3. Danner RL, Elin RJ, Hosseni JM, Reilly JM, Parillo JE. Endotoxemia in septic shock. Chest 1991, 99:169-175. 10.1378/chest.99.1.169, 1984950.
4. Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas H, Braude AI. Treatment of gram negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982, 307:1225-1230. 10.1056/NEJM198211113072001, 6752708.
5. McCall CE, Yoza BK, Liu T, El Gazzar M. Gene specific epigenetic regulation in serious infections with systemic inflammation. J Innate Immun 2010, 2:395-405. 10.1159/000314077, 2968760, 20733328.
6. El Gazzar M, Yoza BK, Chen X, Garcia BA, Young NL, McCall CE. Chromatin-specific remodelling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance. Mol Cell Biol 2009, 29:1959-1971. 10.1128/MCB.01862-08, 2655606, 19158276.
7. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volata G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock. The EUPHAS randomized controlled trial. JAMA 2009, 301:2445-2452. 10.1001/jama.2009.856, 19531784.
8. McIntyre CW, Harrison LEA, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PKT. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011, 6:133-141. 10.2215/CJN.04610510, 3022234, 20876680.
9. Levine D, Parker T, Bologa R, Chevalier J, Gordon B, Foster D, Walker P, Klein D. Patients with chronic kidney disease (CKD) stage 3-5 have endotoxin levels similar to ICU patients with sepsis [abstract]. Am J Soc Nephrol 2007, 18:773A-774A.
10. Levin J, Bang FB. Clottable protein in Limulus, its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 1968, 19:186-197.
11. van Deventer SJ, Buller HR, ten Cate JW, Sturk A, Pauw W. Endotoxemia: an early predictor of septicaemia in febrile patients. Lancet 1988, 1:605-609.
12. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with sepsis syndrome. Ann Intern Med 1993, 119:771-778.
13. Hurley JC. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 1995, 8:268-292. 172859, 7621402.
14. Romaschin AD, Harris DM, Ribeiro MB, Paice J, Foster DM, Walker PM, Marshall JC. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J Immunol Methods 1998, 212:169-185. 10.1016/S0022-1759(98)00003-9, 9672205.
15. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A. Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study. J Infect Dis 2004, 190:527-534. 10.1086/422254, 15243928.
16. Wahl HG. Endotoxin activity assay EAA: measurement of endotoxin activity in whole blood by neutrophil chemiluminescence. Infl ammation Res 2010, 59(Suppl 1):S161.
17. Klein DJ, Derzko A, Foster D, Seely AJE, Brunet F, Romaschin AD, Marshall JC. Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Shock 2007, 28:524-529.
18. Kazuaki A, Hideki S, Shinichi S. Clinical usefulness of a newly developed whole blood endotoxin assay. Japanese J Intensive Care Med 2007, 31:407-410.
19. Novelli G, Ferretti G, Ruberto F, Morabito V, Pugliese F. Early management of endotoxemia using the Endotoxin Acitivity Assay and polymyxin B-based hemoperfusion. Contrib Nephrol 2010, 167:91-101.
20. Charbonney E, Li Y, Klein D, Romaschin A, Nathans AB, Marshall JC. Systemic endotoxemia following multiple trauma is associated with early shock and predicts subsequent mortality. , http://sisna.org/abstracts/2011/23.cgi
21. Dholakia S, Inwald D, Betts H, Nadel S. Endotoxemia in paediatric critical illness - a pilot study. Crit Care 2011, 15:R141. 10.1186/cc10264, 3219013, 21651808.
22. Pathan N, Burmester M, Tanja A, Berk M, Ng KW, Betts H, Macrae D, Waddell S, Paul-Clark M, Nuamah R, Mein C, Levin M, Montana G, Mitchell JA. Intestinal injury and endotoxemia in children undergoing surgery for congenital heart disease. Am J Respir Crit Care Med 2011, 184:1261-1269. 10.1164/rccm.201104-0715OC, 21868501.
23. Klein DJ, Briet F, Nisenbaum R, Romaschin AD, Mazer CD. Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study. Crit Care 2011, 15:R67. 10.1186/cc10047, 3222000, 21342494.
24. Yaroustovsky MB, Abramyan MV, Popok ZV, Nazarova EN, Stupchenko OC, Popov DA, Plusche MG. Selective hemoperfusion in patients with severe gram negative sepsis after cardiac surgery - randomized prospective trial. Anesteziol Reanimatol 2010, 5:60-65.
25. Hilmi I, Kellum JA, Planinsic R, Foster D, Abdullah A, Damian D, Klein D, Abu-Elmagd K. Endotoxemia is common following abdominal organ transplantation and is associated with reperfusion and rejection. J Organ Dysfunction 2009, 5:254-260.
26. Mizuka K, Urahashi T, Ihara Y, Wakiya T, Okada N, Yamada N, Ushijima K, Otomo S, Sakamoto K, Yasuda Y. Impact of hepatic clearance of endotoxin using endotoxin activity assay. Hepatol Int 2011, Epub ahead of print.